TCS 3,545.00 -5.35 (-0.15%) HDFCBANK 1,797.40 +30.10 (1.70%) 
HINDUNILVR 2,242.00 +8.35 (0.37%) INFY 1,549.85 +22.35 (1.46%) HDFC 2,729.95 -17.05 (-0.62%) BHARTIARTL 1,754.75 +30.85 (1.79%) KOTAKBANK 2,153.00 +7.75 (0.36%) ICICIBANK 1,330.75 +13.15 (1.00%) ITC 408.95 +2.30 (0.57%) BAJFINANCE 8,667.95 -28.95 (-0.33%) MARUTI 11,715.05 +239.50 (2.09%) HCLTECH 1,531.85 +2.40 (0.16%) SBIN 775.85 +4.35 (0.56%) NESTLEIND 2,201.85 -30.25 (-1.36%) ASIANPAINT 2,306.65 -8.75 (-0.38%) WIPRO 263.65 +1.00 (0.38%) DMART 4,116.30 +112.15 (2.80%) AXISBANK 1,084.85 -0.50 (-0.05%) LT 3,421.65 -14.20 (-0.41%) HDFCLIFE 695.70 +2.60 (0.38%) SUNPHARMA 1,714.25 +17.30 (1.02%) ULTRACEMCO 11,276.35 -100.00 (-0.88%) ONGC 250.45 +2.30 (0.93%) BAJAJFINSV 1,923.25 -13.25 (-0.68%) BPCL 286.85 +2.05 (0.72%) POWERGRID 286.70 -2.55 (-0.88%) TITAN 3,099.05 +112.55 (3.77%) BRITANNIA 5,048.30 +148.60 (3.03%) NTPC 351.90 -0.25 (-0.07%) Download Unicorn Signals App
By EquityPandit
Lupin has launched generic Methylergonovine Maleate tablets USP, 0.2 mg, in the US. It is used to prevent postpartum hemorrhage.
Methylergonovine Maleate tablet is the generic equivalent of Novartis Pharmaceuticals Corporation’s Methergine. It is suggested for the prevention and control of postpartum hemorrhage. Furthermore, as per IQVIA MAT April 2018, the drug had annual sales of approx USD 71.5 million in US.
